Wikidata entity: Q2325775
C₂₅H₂₇N₉O₈S₂ (P274)
Quantities
| P4250 | defined daily dose | 4 |
| P2067 | mass | 645.142 |
| P233 | canonical SMILES | String | CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=C(C=C2)O)C(=O)NC3C4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O | ??? |
| P373 | Commons category | String | Cefoperazone | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | CCN1CCN(C(=O)C1=O)C(=O)N[C@H](C2=CC=C(C=C2)O)C(=O)N[C@H]3[C@@H]4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O | ??? |
| P2175 | medical condition treated | ... | Q34879 (staphylococcal infection) | staphylococcal infection |
| P2175 | medical condition treated | ... | Q221668 (urinary tract infection) | urinary tract infection |
| P2175 | medical condition treated | ... | Q2622199 (upper respiratory tract infection) | upper respiratory tract infection |
| P2175 | medical condition treated | ... | Q7255052 (Pseudomonas infection) | Pseudomonas infection |
| P2175 | medical condition treated | ... | Q16935263 (Serratia infection) | Serratia infection |
| P2175 | medical condition treated | ... | Q19597369 (gram-negative bacterial infection) | gram-negative bacterial infection |
| P2175 | medical condition treated | ... | Q3776920 (bacterial pneumonia) | bacterial pneumonia |
| P2175 | medical condition treated | ... | Q4227886 (Escherichia coli infectious disease) | Escherichia coli infectious disease |
| P2175 | medical condition treated | ... | Q5442760 (female reproductive system disease) | female reproductive system disease |
| P2175 | medical condition treated | ... | Q6029216 (infectious bone disease) | infectious bone disease |
| P3364 | stereoisomer of | ... | Q27167049 ((6R,7S)-7-[[(2R)-2-[[(4-ethyl-2,3-dioxo-1-piperazinyl)-oxomethyl]amino]-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-3-[[(1-methyl-5-tetrazolyl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid) | (6R,7S)-7-[[(2R)-2-[[(4-ethyl-2,3-dioxo-1-piperazinyl)-oxomethyl]amino]-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-3-[[(1-methyl-5-tetrazolyl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
| P3364 | stereoisomer of | ... | Q63393137 ((6R,7R)-7-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid) | (6R,7R)-7-[[(2S)-2-[(4-ethyl-2,3-dioxopiperazine-1-carbonyl)amino]-2-(4-hydroxyphenyl)acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
| P279 | subclass of | ... | Q271021 (cephalosporin antibiotic) | cephalosporin antibiotic |
| P2868 | subject has role | ... | Q12187 (antibiotic) | antibiotic |
| P2868 | subject has role | ... | Q427492 (enzyme inhibitor) | enzyme inhibitor |
| P2868 | subject has role | ... | Q804539 (bactericide) | bactericide |
| P12081 | WHO Aware Classification | ... | Q122925721 (watch) | watch |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | cefoperazone | ??? |
Why not click here or view trends?
log id: 2743636